Michael Stephen Tung - 19 May 2025 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
EVP & CFO
Signature
/s/ Elizabeth Keiley, as Attorney-in-fact
Issuer symbol
VTVT
Transactions as of
19 May 2025
Net transactions value
+$956,250
Form type
4
Filing time
21 May 2025, 18:17:21 UTC
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tung Michael Stephen EVP & CFO C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310, HIGH POINT /s/ Elizabeth Keiley, as Attorney-in-fact 21 May 2025 0002069755

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTVT Employee stock option (right to buy) Award $956,250 +45,000 $21.25 45,000 19 May 2025 Class A Common Stock 45,000 $21.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests 25% on the 1st anniversary of the grant and the remaining vest quarterly over three years, subject to continued employment.